![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
P Singh and MS Roberts
Department of Pharmacy, University of Queensland, Australia.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are being administered increasingly by transdermal drug delivery for the treatment of local muscle inflammation. The human epidermal permeabilities of different NSAIDs (salicylic acid, diethylamine salicylate, indomethacin, naproxen, diclofenac and piroxicam) from aqueous solutions is dependent on the drug's lipophilicity. A parabolic relationship was observed when the logarithms of NSAID permeability coefficients were plotted against the logarithms of NSAID octanol-water partition coefficients (log P), the optimum log P being around 3. The local tissue concentrations of these drugs after dermal application in aqueous solutions were then determined in a rat model. The extent of local, as distinct from systemic delivery, for each NSAID was assessed by comparing the tissue concentrations obtained below a treated site to those in contralateral tissues. Local direct penetration was evident for all NSAIDs up to a depth of about 3 to 4 mm below the applied site, with distribution to deeper tissues being mainly through the systemic blood supply. A comparison of the predicted tissue concentrations of each NSAID after its application to human epidermis was then made by a convolution of the epidermal and underlying tissue concentration-time profiles. The estimated tissue concentrations after epidermal application of NSAIDs could be related to their maximal fluxes across epidermis from an applied vehicle.
This article has been cited by other articles:
|
|
 |
|
  S. Schmidt, R. Banks, V. Kumar, K. H. Rand, and H. Derendorf Clinical Microdialysis in Skin and Soft Tissues: An Update J. Clin. Pharmacol., March 1, 2008; 48(3): 351 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Esparza, C. Cobian, J. F. Jimenez, J. J. Garcia-Cota, C. Sanchez, A. Maestro, the working group for the acute pain study of SETR, D. Santiago, and M. Cusi Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries * COMMENTARY * COMMENTARY Br. J. Sports Med., March 1, 2007; 41(3): 134 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mazieres, S. Rouanet, J. Velicy, C. Scarsi, and V. Reiner Topical Ketoprofen Patch (100 mg) for the Treatment of Ankle Sprain: A Randomized, Double-Blind, Placebo-Controlled Study Am. J. Sports Med., April 1, 2005; 33(4): 515 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Clough and M. Noble Microdialysis--A Model for Studying Chronic Wounds International Journal of Lower Extremity Wounds, December 1, 2003; 2(4): 233 - 239. [Abstract] [PDF]
|
|
|
|
 |
|
 P. C Panus, K. E Ferslew, B. Tober-Meyer, and R. L Kao Ketoprofen Tissue Permeation in Swine Following Cathodic Iontophoresis Physical Therapy, January 1, 1999; 79(1): 40 - 49. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
